Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in mice.

Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in mice. PLoS One. 2013; 8(7):e69397.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.